|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL.: (2006.01) |
A61K 38/00 A61K 38/16 A61P 1/00 A61P 3/00 A61P 7/00 A61P 17/00 A61P 19/00 A61P 21/00 A61P 25/00 A61P 27/00 A61P 29/00 A61P 35/00 A61P 37/00 A61P 43/00 C07K 14/435 C12N 15/09 C12P 21/02 |
| (11) | Number of the document | 5063 |
| (13) | Kind of document | B |
| (21) | Application number | 2003 002 |
| (22) | Date of filing the application | 2003-01-07 |
| (41) | Date of publication of the application | 2003-07-25 |
| (45) | Date of publication of patent | 2003-11-25 |
| (86) | Number | PCT/US01/21204 |
| Date | 2001-07-02 |
| (87) | Number | WO 02/02638 |
| Date | 2002-01-10 |
| (30) | Number | Date | Country code |
| 60/215,913 | 2000-07-03 | US |
| (71) |
BRISTOL-MYERS SQUIBB COMPANY,
P.O.Box 4000, Lawrenceville-Princeton Road, Princeton, NJ 08543-4000,
US
|
| (72) |
Robert J. PEACH, US
Robert COHEN, US Suzette CARR, US David HAGERTY, US Jean Claude BECKER, US |
| (73) |
BRISTOL-MYERS SQUIBB COMPANY,
P.O.Box 4000, Lawrenceville-Princeton Road, Princeton, NJ 08543-4000,
US
|
| (74) |
Rita LAURINAVIČIŪTĖ,
Gedimino pr. 45-6, LT-01109 Vilnius,
LT
|
| (54) | A SOLUBLE CTLA4 MOLECULE FOR USE IN THE TREATMENT RHEUMATIC DISEASES |
| Payment date | Validity (years) | Amount | |
| 2020-06-26 | 20 | 347.00 EUR |